The Peptide Progress Independent peptide research guides

Research library

TB-500 and thymosin beta-4: naming, evidence and testing

Why two labels are often treated as synonyms online even though analytical identity requires much more precision.

By The Peptide Progress Editorial TeamLast reviewed 19 September 2026Reading time 7 minutesCited sources 2

Research context only

This article describes terminology, published research and analytical questions. It does not establish clinical benefit, safety or approval and gives no personal-use guidance.

Overview

Thymosin beta-4 is a naturally occurring 43-amino-acid peptide studied in cell biology and tissue models. “TB-500” is a commercial or informal label used inconsistently online, sometimes for full-length thymosin beta-4 and sometimes for related material.

Identity and naming

A report should never rely on “TB-500” alone. It should state the exact sequence, terminal chemistry, molecular formula or theoretical mass, form and batch. Without those fields, readers cannot know whether two documents describe the same material.

What the evidence does—and does not—show

Published thymosin beta-4 work cannot automatically be assigned to every product sold under the TB-500 label. Evidence transfer requires identity, form and experimental conditions to match.

Analytical questions

  • Demand the full sequence behind the trade-style name.
  • Compare observed and theoretical mass.
  • Check for possible truncations or related peptides.
  • Read purity and content as separate measurements.

For document checks, use the COA guide and testing-method overview.

Reading supplier and search claims

A research paper and a batch report answer different questions. Published literature may explain why a compound is studied; it does not verify the identity, content, sterility or provenance of material offered under the same name. Read supplier statements as claims to check, then match the physical batch to the laboratory evidence.

Related external reading:

Editorial reference only; not an endorsement or batch verification.

Frequently asked questions

Are TB-500 and thymosin beta-4 always identical?

No. TB-500 is used inconsistently, so the exact sequence and molecular form must be stated.

Can a name on a label establish identity?

No. Identity requires suitable analytical evidence connected to the labelled batch.

Sources and further reading

  1. Goldstein AL et al. Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues. Search PubMed.
  2. IUPAC peptide terminology.

External sources were checked on 19 September 2026. A citation supports the statement beside it; it does not imply that a source endorses this publication or any supplier.